ʻaoʻao_banner

huahana

ʻO Palmitoylethanolamide (PEA Micro) mea hana pauka CAS No.: 544-31-0 99% maemae min.no nā mea hoʻohui

ʻO ka wehewehe pōkole:

ʻO ka PEA he amide momona momona maoli i hana ʻia mai ka ethanolamine a me ka palmitic acid, ʻike ʻia i loko o nā ʻōpū holoholona, ​​nā yolks hua manu, ka aila ʻoliva, safflower, soy lecithin, nā pīni a me nā meaʻai ʻē aʻe.


Huahana Huahana

Huahana Huahana

Nā Kūlana Huahana

Inoa mea kūʻai

PEA micro

inoa ʻē aʻe

N-(2-HYDROXYETHYL)HEXADECANAMIDE;

N-HEXADECANOYLETHANOLAMINE;

PEAPALMIDROL;

PALMITYLETHANOLAMIDE;

PALMITOYLETHChemicalbookANOLAMIDE

CAS No.

544-31-0

ʻAno molekala

C18H37NO2

Kaumaha molekula

299.49

Maemae

99.0%

Ka nana aku

ʻO ka pauka kristal keʻokeʻo

Hoʻopili

25Kg/ pahu

Palapala noi

Nā mea maka o nā huahana mālama ola

Hoʻolauna huahana

ʻO ka PEA he amide momona momona maoli i hana ʻia mai ka ethanolamine a me ka palmitic acid, ʻike ʻia i loko o nā ʻōpū holoholona, ​​nā yolks hua manu, ka aila ʻoliva, safflower, soy lecithin, nā pīni a me nā meaʻai ʻē aʻe.ʻO ka PEA kahi mea hoʻohuihui kūlohelohe a me ka lāʻau lapaʻau waena, hiki ke hoʻohana ʻia i ka ʻimi noiʻi a me ke kaʻina hana hoʻomohala a me ke kaʻina noiʻi lāʻau lapaʻau a me ka hoʻomohala ʻana.ʻO PEA MICRO kahi agonist receptor endocannabinoid.Loaʻa i ka PEA kahi ākea o nā noi lapaʻau kūpono, akā ʻo kāna noiʻi a me nā hoʻohana kaulana e nānā nui i nā hopena anti-inflammatory a me analgesic o ka ʻeha hope haʻahaʻa, ka ʻeha aʻalolo sciatic, ka osteoarthritis a me nā maʻi ʻē aʻe.No ka ʻohana lipid a me ka ʻohana n-acylethanolamine.Kāohi ʻo PEA MICRO i ka hoʻokuʻu ʻia ʻana o nā mea hoʻolaha pro-inflammatory mai nā mast cell i hoʻōla ʻia a pale i ka hoʻopaʻa ʻia ʻana o nā mast cell i hoʻāla ʻia ma nā wahi hōʻeha nerve.ʻO ka PEA kahi amide fatty acid endogenous, no ka papa o nā agonists nuklea.Ua hōʻike ʻia e hoʻopaʻa i nā mea hoʻopaʻa nuklea (nā mea hoʻopaʻa nuklea) a hoʻoikaika i nā ʻano hana olaola e pili ana i ka ʻeha mau a me ka mumū.ʻIke ʻia ʻo PEA ma ke ʻano he "molekele hōʻailona lipid hoʻonā hoʻonā.Ua noiʻi pū nā haʻawina preclinical a me ke kanaka i kona hopena i ke kaumaha, hoʻonui i ka hana noʻonoʻo a me ka hoʻomanaʻo, autism, multiple sclerosis, obesity and metabolic syndrome.

Hiʻona

ʻO nā pono olakino o ka PEA e pili ana i ka hoʻopili ʻana i nā cell immune e hoʻomalu i ka mumū, ʻoi aku hoʻi i ka lolo.Hiki i ka PEA ke kōkua i ka hoʻemi ʻana i ka hana ʻana o nā mea ʻona.Akā, hana nui ʻo PEA i nā mea loaʻa i nā cell e mālama i nā ʻano āpau o ka hana cell.Ua kapa ʻia kēia mau mea loaʻa he PPars.Hiki i ka PEA a me nā pūhui ʻē aʻe ke kōkua i ka hoʻoikaika ʻana i nā PPA ke hōʻemi i ka ʻeha, a me ka hoʻonui ʻana i ka metabolism ma ka puhi ʻana i ka momona, hoʻohaʻahaʻa i ka triglycerides serum, hoʻonui i ka cholesterol HDL serum, hoʻomaikaʻi i ka hoʻokele koko koko a kōkua i ka pohō kaumaha.

Nā noi

Ua hōʻike ʻia ʻo PEA he anti-inflammatory, anti-sensory injury, neuroprotective, a me nā waiwai anticonvulsive.Ke ʻimi nei ʻo PEA i nā ʻano ʻeha like ʻole i ka poʻe i nā hoʻokolohua lapaʻau like ʻole no nā maʻi ʻeha a me nā maʻi ʻeha.Hoʻoponopono ka PEA i nā kaʻina hana physiological, me ka ʻike ʻeha, convulsions, a me ka neurotoxicity.


  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou